Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-23 2:32 pm Sale | 2023-06-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM | New Enterprise Associates 16, L.P. | 2,186,243 5.800% | -2,000,000 (-47.78%) | Filing History |
| 2023-05-03 4:58 pm Sale | 2023-05-03 | 13G | Mirum Pharmaceuticals, Inc. MIRM | James E. Flynn | 0 0.000% | -2,032,335 (Position Closed) | Filing History |
| 2023-04-14 12:45 pm Purchase | 2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX L.P. | 4,411,107 11.600% | 549,326 (+14.22%) | Filing History |
| 2023-03-08 2:15 pm Sale | 2023-02-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 1,677,907 4.600% | -458,770 (-21.47%) | Filing History |
| 2023-02-14 3:00 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Rock Springs Capital Management LP | 1,795,733 4.870% | 256,919 (+16.70%) | Filing History |
| 2023-02-14 1:34 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 2,057,000 5.600% | 2,057,000 (New Position) | Filing History |
| 2023-02-10 09:34 am Unchanged | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | James E. Flynn | 2,032,335 5.510% | 0 (Unchanged) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BlackRock Inc. BLK | 2,136,677 5.800% | 2,136,677 (New Position) | Filing History |
| 2022-12-01 11:07 am Purchase | 2022-11-11 | 13D | Mirum Pharmaceuticals, Inc. MIRM | RiverVest Venture Fund IV L.P. | 1,621,118 4.400% | 1,621,118 (New Position) | Filing History |
| 2022-09-12 5:23 pm Sale | 2022-09-08 | 13G | Mirum Pharmaceuticals, Inc. MIRM | James E. Flynn | 2,032,335 5.530% | -1,250,577 (-38.09%) | Filing History |
| 2022-08-18 1:30 pm Sale | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,760,000 4.800% | -129,127 (-6.84%) | Filing History |
| 2022-08-16 12:20 pm Purchase | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX L.P. | 3,861,781 10.500% | 294,869 (+8.27%) | Filing History |
| 2022-08-02 3:31 pm Sale | 2022-08-01 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,889,127 5.900% | -310,873 (-14.13%) | Filing History |
| 2022-04-08 2:49 pm Sale | 2022-03-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,200,000 6.900% | -245,147 (-10.03%) | Filing History |
| 2022-02-14 6:23 pm Purchase | 2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Rock Springs Capital Management LP | 1,538,814 5.020% | 42,289 (+2.83%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | James E. Flynn | 3,282,912 10.720% | -166,000 (-4.81%) | Filing History |
| 2021-10-25 06:07 am Sale | 2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM | TAKEDA PHARMACEUTICAL CO LTD | 530,562 1.700% | -1,328,589 (-71.46%) | Filing History |
| 2021-08-24 4:32 pm Unchanged | 2021-08-19 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,445,147 8.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:32 pm Purchase | 2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Rock Springs Capital Management LP | 1,496,525 5.080% | 251,525 (+20.20%) | Filing History |
| 2021-01-27 06:02 am Unchanged | 2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | TAKEDA PHARMACEUTICAL CO LTD | 1,859,151 7.200% | 0 (Unchanged) | Filing History |